Are your eyes constantly stinging, watering, or feeling like they’re filled with grit? Does digital screen time, air conditioning, or contact lenses make things worse? If that sounds familiar, you might be one of the over 4.3 million Australians living with dry eye disease, a condition that affects everyday comfort and visual clarity.
I’m Dr Erica Darian-Smith, a corneal sub-specialist and ophthalmologist at Eagle Eye Surgeons in Sydney. Our team runs a dedicated dry eye spa offering medical and advanced laser dry eye treatments. In this article, I’ll explain what causes dry eyes, how we treat them, including Intense Regulated Pulse Light (IRPL) with the next-generation TearStim device, and what results you can expect.
Key Takeaways
- IRPL with TearStim is a clinically effective treatment for Meibomian Gland Dysfunction.
- Each IRPL session is quick, non-invasive, and suitable for moderate to severe cases.
- Maintenance treatments every 3–6 months may prolong symptom relief.
- We combine laser therapy with other proven treatments for long-term results.
What Is Dry Eye Disease?
Dry eye reduces tear production or speeds up tear evaporation, which disrupts eye comfort. This leads to irritation, blurred vision, and ongoing discomfort. Ageing, extended screen use, eyelid conditions like blepharitis and systemic issues such as ocular rosacea or Sjögren’s syndrome often cause or contribute to the problem.
At our clinic, we use tools like the Ocular Surface Disease Index (OSDI), tear break-up time tests, and gland imaging to diagnose dry eye disease. We tailor each treatment plan based on whether the dry eye is aqueous-deficient, evaporative, or a combination of both.
Symptoms of Dry Eye Disease
How do you know if what you have is dry eye and not something else? For starters, dry eye can present in several ways. Patients often report a mix of visual and sensory discomfort that comes and goes, or sometimes lingers all day.
Some of the most common symptoms include:
- A persistent dry, gritty, or stinging sensation, especially after reading or screen use
- Eye redness and irritation that worsens as the day progresses
- Blurred or fluctuating vision, particularly with extended focus
- Watery eyes that don’t actually relieve the dryness
- Sensitivity to light or wind exposure
- A burning sensation following prolonged screen time or in dry environments
IRPL Dry Eye Treatment Explained
| Treatment Step | Details |
| Technology Used | TearStim (latest-gen IRPL) |
| Target Condition | Meibomian Gland Dysfunction (MGD), Ocular Rosacea |
| Procedure Duration | A few minutes per session |
| Sessions Required | Four treatments spaced over 2–3 months |
| Maintenance | Every 3–6 months if needed |
| Patient Comfort | Non-invasive, no downtime, protective eyecups and cooling gel applied |
| Expected Benefits | Reduced inflammation, restored oil flow, longer tear film stability |
IRPL (Intense Regulated Pulsed Light) therapy is a light-based treatment designed specifically for Meibomian Gland Dysfunction (MGD). It targets inflammation and reactivates oil production in the eyelids to restore the tear film. At Eagle Eye Surgeons, we use TearStim, the latest generation of IRPL.
During treatment, protective eyecups are worn, and a cooling gel is applied to the lower eyelids. Light pulses are delivered gently across the area in a session that takes only a few minutes. The procedure is non-invasive, painless, and requires no time off work. But we do advise avoiding direct sunlight for the first 48 hours post-treatment.
Four treatments over two to three months complete the treatment protocol. Most patients report relief lasting six months to three years. Maintenance sessions may be needed every three to six months for best ongoing results.
With IRPL, you can expect the following benefits:
- Shrinks abnormal blood vessels to reduce inflammation
- Unblocks meibomian glands and improves oil secretion
- Reduces Demodex mites and bacteria
- Stabilises the tear film’s lipid layer
Who Is IRPL For?
Should you try IRPL therapy? IRPL is most effective for people diagnosed with Meibomian Gland Dysfunction (MGD), or those experiencing rosacea-related dry eye. It also benefits those whose symptoms haven’t improved with drops or warm compresses.
- If your current dry eye treatment plan feels like it’s falling short, IRPL may offer a more lasting solution.
- On the other hand, this treatment may not be recommended during active eye infections, during pregnancy, or for those with light-sensitive skin or who are on certain medications.
We’ll always confirm your eligibility in a face-to-face consult before beginning.
Benefits of IRPL Dry Eye Treatment
Short-term relief is common. Many patients notice less grittiness, stinging, and reliance on artificial tears after the first few sessions. With time, IRPL improves the function of your meibomian glands and helps rebuild a stable tear film. This leads to more consistent comfort throughout the day.
How about the cosmetic benefits of IRPL therapy? The light pulses may reduce facial redness and improve the appearance of the lower eyelid skin. One therapy, multiple gains!
How IRPL Compares
| Treatment | Delivery Method | Main Mechanism | Ideal For | Limitations |
| IRPL (TearStim) | Non-contact light pulses | Gland reactivation and inflammation control | MGD and ocular rosacea | May require maintenance sessions |
| Blephasteam | Warm compress device | Heat melts gland blockages | Mild gland dysfunction | Does not treat inflammation |
| LipiFlow | Heat + mechanical pressure | Physical gland expression | Blocked but functional glands | Requires eye contact and may not suit all anatomies |
| Artificial Tears | Lubricant drops | Surface hydration | Mild or temporary symptoms | No impact on underlying causes |
Each treatment listed in the table above addresses dry eye from a different angle. IRPL is the most comprehensive, using pulsed light to target inflammation and restore oil flow in rosacea-related or moderate-to-severe dry eye.
Blephasteam works best for mild or early dysfunction by applying consistent heat, though it doesn’t treat inflammation. LipiFlow combines heat with mechanical pressure to express blocked glands, but it requires physical contact and may not suit patients with deep-set eyes. Artificial tears remain the easiest option, but they only mask symptoms without resolving the root cause.
IRPL Cost in Sydney
Each session costs $258 and includes manual meibomian gland expression. A full course of four treatments is $1032. Our pricing is transparent and all-inclusive. Medicare does not cover IRPL, but some private health funds may offer partial rebates. We’ll provide a detailed invoice so you can submit a claim if eligible.
Final Thoughts
Dry eye disease is a common condition that interferes with everyday life, but effective solutions are available. IRPL therapy targets the root cause of inflammation and blocked glands, offering relief where drops and compresses fall short.
From early symptom relief to long-term stability, IRPL is a dry eye treatment worth considering if you’re seeking more than temporary comfort. At Eagle Eye Surgeons, we deliver evidence-based care supported by modern diagnostics and a commitment to long-term outcomes.
Take the next step toward clearer, more comfortable vision. Book a consultation today and explore your options for dry eye treatment.
We have two convenient locations in Sydney. Our Mosman clinic on the Lower North Shore offers ground floor access, on-site parking, and excellent public transport links. Our Nepean clinic offers two hours of free on-site parking and easy access opposite Nepean Hospital. You can call us on (02) 7228 3900 (MOSMAN) or (02) 7228 3556 (NEPEAN) or arrange an appointment online through this website.
Want to learn more? Listen to the following podcast episode.

– Fellow of the Royal Australian and New Zealand College of Ophthalmologists (FRANZCO)
– Fellow of World College of Refractive Surgery and Visual Sciences (FWCRS)
– GradDipGraduate Diploma in Cataract and Refractive Surgery (University of Sydney)
– Master of Medicine (MMed, Ophthalmic Sciences, University of Sydney)
– Bachelor of Medicine and Surgery (MBBS, University of Tasmania)
Dr. Erica was a recipient of the 2022 ASCRS Foundation Resident Excellence Award. In 2019, she was awarded the RANZCO Filipic Greer Medal for overall excellence in performance at the RANZCO Ophthalmic Pathology examination. Most recently, she was awarded the Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Trevalyn-Smith Travelling Scholarship to subsidize overseas study for Fellows.
As an accomplished researcher Dr. Erica’s work has been published widely in high quality medical journals, including the American Journal of Ophthalmology, the Journal of Cataract and Refractive Surgery, the European Journal of Ophthalmology and Clinical and Experimental Ophthalmology. Erica has also written a book chapter and has had the opportunity to present her research at various international and national conferences. Dr. Erica is appointed as a Clinical Lecturer in the Discipline of Ophthalmology at the University of Sydney, Save Sight Institute and regularly contributes to ongoing teaching in her area of subspeciality.

